Pith. sign in

REVIEW 3 major objections 5 minor 123 references

This paper argues that epidemic response can be structured as a closed-loop, data-driven DMAIC cycle, demonstrated on COVID-19.

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

The paper repackages known system-informatics and epidemiological tools into a DMAIC framework for epidemic response, with illustrative but unvalidated COVID-19 case studies.

T0 review reviewed 2026-08-02 challenge →

load-bearing objection Competent DMAIC-framed review of epidemic informatics; the organizing framework is useful, but the uncalibrated simulation behind the headline NPI claims should be reframed as illustrative, not evidence. the 3 major comments →

arxiv 2607.13914 v1 pith:CBGRJVOI submitted 2026-07-15 eess.SY cs.CYcs.SYstat.AP

Epidemic Informatics and Control: A Holistic Approach from System Informatics to Epidemic Response and Risk Management in Public Health

Hui Yang , Siqi Zhang , Runsang Liu , Alexander Krall , Yidan Wang , Marta Ventura , Chris Deflitch This is my paper
classification eess.SY cs.CYcs.SYstat.AP
keywords infectious diseaseepidemicdiagnostic testingrisk managementhealth systemsdata analyticssimulation modelingartificial intelligence
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Epidemic response usually unfolds as improvisation: testing expands, models are built, policies change. This paper's thesis is that the same Define-Measure-Analyze-Improve-Control (DMAIC) cycle used for quality improvement in manufacturing can give public-health response a disciplined, data-driven structure. It covers the full loop—sampling and testing strategies, regression and spatiotemporal analytics, privacy-preserving modeling, health-system resilience, resource siting, and simulation of non-pharmaceutical interventions—and illustrates each stage with COVID-19 data. If the thesis holds, epidemic management becomes a learnable engineering process instead of a sequence of reactive judgment calls.

Core claim

The paper's central claim is that an epidemic can be managed as a closed-loop system-informatics problem. It argues that each phase of DMAIC has a concrete toolkit: Define frames the health and economic burden; Measure turns testing into statistical sampling and surveillance; Analyze extracts predictive features, builds sparse regression models, and adds differential privacy; Improve redesigns hospitals and places resources via Voronoi-based coverage control; Control benchmarks stay-at-home, social distancing, and other policies in a discrete-event simulation of human traffic on a spatial network. On its own case study, the paper reports that county-level models explain most of the variation

What carries the argument

The load-bearing object is the DMAIC cycle itself: a five-phase closed loop in which data from testing feed predictive models, models inform system redesign, and simulation experiments evaluate policy interventions, with each phase's output becoming the next phase's input. Within the control phase, the key mechanism is a discrete-event simulation on a spatial network whose infection probability is p_i = 1 − exp(τ Σ_r N_r ln(1 − r s_i ρ)), combining exposure time, virus transmissibility, carrier infectivity, and individual susceptibility. The simulation is what turns the framework from description into a tool for comparing policies.

Load-bearing premise

The policy conclusions depend on a computer simulation whose infection-probability parameters were chosen rather than fitted to real outbreak data; if that transmission model does not reflect reality, the headline results about stay-at-home and other interventions do not follow.

What would settle it

Re-estimate the infection probability parameters from location-specific case counts and mobility data, rerun the simulation, and compare the simulated infection-peak timing and magnitude with observed county trajectories; if the gap between stay-at-home and no-intervention scenarios shrinks to near zero under fitted parameters, the central policy claim is falsified.

Watch this falsifier. Get emailed when new claim-graph text bears on it.

If this is right

  • Epidemic agencies can organize testing, analytics, hospital planning, and policy as one feedback loop, with explicit handoffs between stages.
  • Acceptance-sampling plans give a statistical rule for deciding when a region can reopen or must lock down, rather than threshold-by-whim.
  • Sparse county-level regression can explain a large share of variation in cumulative COVID-19 cases, so routinely collected predictors have forecasting value.
  • Coverage-control placement of testing or vaccination sites can balance travel access with equitable distribution of scarce resources.
  • Simulation experiments suggest that stay-at-home and combined non-pharmaceutical interventions materially flatten infection curves; the order and timing of triggers matter.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • A natural extension is to operationalize the DMAIC cycle as a performance audit: measure variance explained or decision loss at each phase to find where epidemic response loses the most information.
  • The policy conclusions in the control phase rest on an uncalibrated infection model; fitting its parameters to real case and mobility data could turn the illustrative 'what-if' curves into quantitative policy forecasts.
  • The same acceptance-sampling logic could be fused with multivariate surveillance: a Hotelling T2 signal could trigger lot-level testing, making lockdown decisions adaptive in space and time.
  • Differential-privacy gradient perturbation suggests a concrete experiment for multi-jurisdiction data sharing: merge cohort data under privacy guarantees and measure how model accuracy changes versus attack resistance.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 5 minor

Summary. The paper proposes a holistic system informatics approach—Define, Measure, Analyze, Improve, Control (DMAIC)—for epidemic response and management, illustrated through COVID-19. It reviews challenges to health systems and the economy; presents testing and sampling methods; analyzes county-level COVID-19 data with correlation and lasso regression; discusses spatiotemporal modeling and privacy-preserving analytics; describes AI-driven health-system resilience, a greedy-Voronoi algorithm for resource allocation, and hospital redesign; and develops a discrete-event simulation (DES) of epidemic spread in a spatial network to evaluate non-pharmaceutical interventions (NPIs). The central claim is that the DMAIC framework provides a useful organizing cycle that integrates data, statistics, and optimization for epidemic control. The paper includes several illustrative case studies, but the quantitative support for the Control phase rests on an uncalibrated simulation, and the descriptive analytics lacks out-of-sample validation.

Significance. If the central claim holds, the paper offers a valuable systems-level synthesis for epidemic informatics, connecting data collection, predictive modeling, health-system redesign, and policy simulation within a single framework. The review portions on testing, data sources, visualization, and hospital redesign are broad and timely. The paper also contributes a privacy-preserving gradient perturbation algorithm and a greedy-Voronoi facility allocation method, both of which could be of interest to the community. However, the strength of the quantitative evidence is uneven: the descriptive analytics reports only in-sample fit, the DES simulation is uncalibrated, and the privacy results lack experimental detail. These weaknesses limit the paper's ability to support its more assertive policy claims, though the framework itself remains plausible if those case studies are reframed as illustrative or properly validated.

major comments (3)
  1. [Section VI.B/C, Eq. (10)] The infection probability model p_i = 1 − exp(τ Σ_r N_r ln(1 − r s_i ρ)) is never calibrated or validated against observed epidemic data. The parameters ρ (0.00025, 0.0005, 0.001), susceptibility s_i, exposure time τ, infectivity r, time lags, and the 67% activity reduction under stay-at-home are all chosen arbitrarily. The conclusions in Section VI.C, including 'the stay-at-home policy is critical to stopping the virus spread and flattening the curve,' are direct consequences of the model definition: reducing activity reduces contact counts, and the infection probability is monotonically increasing in contact counts. This is a circularity concern. The authors should either calibrate the simulation to empirical infection trajectories, compare its outputs with established compartmental models, or explicitly re-frame the simulation as an illustrative what-if tool and temper the policy conc
  2. [Section IV.A, data exclusions and R²] The descriptive analytics uses 2781 of 3141 counties (Section IV.A) but does not explain why 360 counties are excluded. If the exclusions are due to missing data, this should be stated and examined for potential bias. Moreover, the adjusted R² values (71–94% in Figure 13) are in-sample fit statistics; they do not demonstrate predictive validity. The text in Section IV.A.2 claims 'the high adjusted R² values show the predictability of fixed-effect models,' but predictability requires out-of-sample or cross-validated evaluation. The lasso step uses 10-fold cross-validation to select λ, but the subsequent fixed-effect models are not evaluated on a held-out test set. Please add a proper train/test split or temporal validation and report prediction errors on unseen data.
  3. [Section IV.C, Figure 17] The privacy-preserving gradient perturbation algorithm in Table 6 is presented as a 'newly revised implementation,' but the manuscript provides no formal privacy guarantee or convergence analysis. Figure 17 shows privacy model and attack accuracies versus ε, yet the experimental setup is missing: what dataset, model, and attack method were used? What are the hyperparameters Λ, Κ, b, θ? Without these details, the claim that attack accuracy approaches zero while model accuracy decreases by only ~5% cannot be reproduced or assessed. If this algorithm is a contribution, it needs rigorous privacy accounting (e.g., composition) and experimental reproducibility.
minor comments (5)
  1. [Equation numbering] Definition 1 is numbered as (1), which duplicates the confidence interval equation in Section III.A. Please renumber the differential privacy definition (e.g., Def. 1 without an equation number, or (2)).
  2. [Section IV.A, Figure 11] The text references 'Error! Reference source not found' for the scatter plots of cumulative cases per capita. The cross-reference to Figure 11 is broken and should be fixed.
  3. [Section VI.C, Figure 25] In Figure 25(b), the text reports '85.48%%' with a doubled percent sign. Please correct the typographical error throughout the section.
  4. [Section V.B, Algorithm 1] The greedy-Voronoi algorithm is compared only against its own convergence behavior. A comparison with alternative placement heuristics (e.g., k-means, maximizing coverage) would strengthen the claim of balance between accessibility and equity. This is not blocking, but would improve the evidence.
  5. [General] The paper is unusually broad, and some sections are review-like while others are research contributions. The authors should clearly distinguish between literature review and novel contributions, perhaps by adding a 'Contributions' paragraph at the end of the introduction.

Circularity Check

0 steps flagged

No circular derivation: the DMAIC framework is organizational and the NPI simulation is an explicit what-if experiment; uncalibrated parameters are a validation concern, not circularity.

full rationale

The paper's central contribution is a review-based DMAIC framework for epidemic informatics, not a derived quantitative result. The only quantitative outputs are the discrete-event simulation experiments in Section VI, which are explicitly framed as 'computer experiments' and 'what-if' analyses. Equation (10) defines infection probability as a monotone function of exposure to carriers, so the stay-at-home scenario (activity reduced to 67%) lowering infection peaks is a direct logical consequence of the model. However, the paper presents this as a model-based scenario analysis rather than as an empirically fitted prediction, so it is not a case where a fitted parameter is renamed as a prediction. The privacy-preserving algorithm in Section IV.C is described as a new implementation with the algorithm and simulation results stated in the paper; self-citations [59,60] provide context but are not load-bearing. Other self-citations are illustrative examples or supplementary references. No step in the paper's derivation chain reduces to its own inputs by construction; the lack of calibration of the simulation is a validity/evidence limitation, not circularity.

Axiom & Free-Parameter Ledger

8 free parameters · 5 axioms · 0 invented entities

The paper's central framework is a proposal, so it does not derive a target result from axioms. The quantitative illustrations, however, rest on many hand-chosen simulation parameters (ρ, asym/sym ratios, activity reduction, time lags) and unvalidated model assumptions (Eq. 10, node-only transmission). The privacy algorithm is a variant of the authors' prior work, and the descriptive regression uses data-driven but unvalidated model selection.

free parameters (8)
  • virus transmissibility ρ = 0.00025, 0.0005, 0.001 (three scenarios)
    Chosen by hand in Section VI.C simulation; not estimated from data.
  • asymptomatic-to-symptomatic ratio = 3:1, 1:1, 1:3
    Assumed scenarios in Figure 24; not based on a fitted value.
  • activity reduction under stay-at-home = reduce daily activities to 67%
    Assumed in Section VI.C; not derived from mobility data (though Google mobility data were used elsewhere).
  • exposure time τ, infectivity r, susceptibility s_i = not specified numerically
    Parameters of Eq. (10); values are not given in the paper, making the simulation irreproducible.
  • time lags: self-isolation and recovery/death = 1 day and 14 days (means)
    Assumed mean lags in Section VI.B; cited refs [121,122] but not fitted.
  • lasso regularization λopt = selects 19 predictors
    Chosen by 10-fold cross-validation in Section IV.A.2; the resulting model is not validated out-of-sample.
  • number of drive-thru sites I and step size α = I=100; α not specified
    Parameters in greedy-Voronoi case study, Section V.B; α is not given.
  • privacy algorithm hyperparameters ε, Λ, Κ, b, θ = ε varied 10^-4 to 10^0; others unspecified
    Hyperparameters in Table 6; Figure 17 varies ε but gives no dataset or error bars.
axioms (5)
  • standard math Binomial approximation to hypergeometric sampling is valid when sample fraction < 1/10
    Section III.A acceptance sampling uses binomial OC curves and sample-size formulas.
  • domain assumption Incidence-rate feature vectors across regions are approximately multivariate normal
    Section III.B, Eq. (4); paper acknowledges slight deviations will not severely impact results [36].
  • ad hoc to paper Infections occur primarily at network nodes, rarely on paths
    Section VI.B defines the simulation and infection model on this basis.
  • domain assumption The 72 county-level predictors from 2018 Census, County Health Rankings, and Google mobility are relevant to 2020 COVID-19 spread
    Section IV.A uses these static/demographic/mobility data without formal justification of temporal relevance.
  • domain assumption DMAIC transfers from manufacturing to epidemic response
    Core of the paper: the framework's applicability is asserted by analogy, not proven.

reviewed 2026-08-02 · how reviews work

0 comments
Cite this review

Pith. "Pith review of Epidemic Informatics and Control: A Holistic Approach from System Informatics to Epidemic Response and Risk Management in Public Health." pith.science (2026). https://pith.science/paper/CBGRJVOI

@misc{pith2026260713914,
  author       = {Pith},
  title        = {Pith review of: Epidemic Informatics and Control: A Holistic Approach from System Informatics to Epidemic Response and Risk Management in Public Health},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/CBGRJVOI}},
  note         = {Machine review of arXiv:2607.13914}
}
Share X Bluesky LinkedIn Reddit HN
read the original abstract

This paper presents a holistic systems informatics approach, i.e., Define, Measure, Analyze, Improve, and Control (DMAIC), for epidemic response and management through the intensive use of data, statistics and optimization. Despite the sustained successes of system informatics in a variety of established industries such as manufacturing, logistics, services and beyond, there is a dearth of concentrated review and application of the data-driven DMAIC approach in the context of epidemic outbreaks. First, we define specific challenges posed by epidemic outbreaks to populational health, health systems, as well as economic challenges to different industries such as retailing, education and manufacturing. Second, we present a review of medical testing and statistical sampling methods for data collection, as well as existing efforts in data management and data visualization. Third, we discuss the importance to realizing the full potential of data for epidemic insights, and emphasize the need to leverage analytical methods and tools for decision support. Fourth, an epidemic brings imperative changes to health systems. We discuss the new trend of healthcare solutions to improve system resilience, including telehealth, artificial intelligence, resource allocation, and system re-design. In closing, prescriptive approaches are discussed to optimize the health policies and action strategies for controlling the spread of virus. We posit that this work will catalyze more in-depth investigations and multi-disciplinary research efforts to accelerate the application of system informatics methods and tools in epidemic response and risk management.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

123 extracted references

  1. [1]

    https://www.cdc.gov/coronavirus/2019-ncov/

    Coronavirus Disease 2019 (COVID-19) in the U.S. https://www.cdc.gov/coronavirus/2019-ncov/

    2019

  2. [2]

    The Bureau of Labor Statistics: Supplemental data measuring the effects of the coronavirus (COVID-

  3. [3]

    Financial markets under the global pandemic of COVID-19,

    D. Zhang, M. Hu and Q. Ji, "Financial markets under the global pandemic of COVID-19," Finance Research Letters, pp. 101528, 2020

    2020

  4. [4]

    The 1918 “Spanish flu

    A. Trilla, G. Trilla and C. Daer, "The 1918 “Spanish flu” in Spain," Clinical Infectious Diseases, vol. 47, no. 5, pp. 668-673, 2008

    1918

  5. [5]

    A study of excess mortality during influenza epidemics in the United States, 1968–1976,

    D. Alling, W. Blackwelder and C. Stuart-Harris, "A study of excess mortality during influenza epidemics in the United States, 1968–1976," Am. J. Epidemiol., vol. 113, no. 1, pp. 30-43, 1981

    1968

  6. [6]

    2009 H1N1 Influenza,

    S. J. Sullivan, R. M. Jacobson, W. R. Dowdle and G. A. Poland, "2009 H1N1 Influenza," Mayo Clinic Proceedings, vol. 85, no. 1, pp. 64-76, 2010

    2009

  7. [7]

    Capturing a killer flu virus,

    J. K. Taubenberger, A. H. Reid and T. G. Fanning, "Capturing a killer flu virus," Scientific American, vol. 292, no. 1, pp. 62-71, 2005

    2005

  8. [8]

    Disease Burden of Influenza, https://www.cdc.gov/flu/about/burden/index.html

  9. [9]

    The reproductive number of COVID-19 is higher compared to SARS coronavirus,

    Y. Liu, A. A. Gayle, A. Wilder-Smith and J. Rocklöv, "The reproductive number of COVID-19 is higher compared to SARS coronavirus," Journal of Travel Medicine, vol. 27, no. 2, pp. taaa021, 2020. 38

    2020

  10. [10]

    N. G. Davies, A. J. Kucharski, R. M. Eggo, et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: A modelling study. The Lancet Public Health vol. 5, no. 7, pp. e375-e385, 2020

    2020

  11. [11]

    Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape,

    N. Ravi, D. L. Cortade, E. Ng and S. X. Wang, "Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape," Biosensors and Bioelectronics, vol. 165, pp. 112454, 2020

    2020

  12. [12]

    Six- Sigma Quality Management of Additive Manufacturing,

    H. Yang, P. Rao, T. Simpson, Y. Lu, P. Witherell, A. R. Nassar, E. Reutzel and S. Kumara, "Six- Sigma Quality Management of Additive Manufacturing," Proceedings of the IEEE, pp. 1-30, 2020

    2020

  13. [13]

    A conceptual model for the application of Six Sigma methodologies to supply chain improvement,

    G. Knowles, L. Whicker, J. H. Femat and F. D. C. Canales, "A conceptual model for the application of Six Sigma methodologies to supply chain improvement," International Journal of Logistics: Research and Applications, vol. 8, no. 1, pp. 51-65, 2005

    2005

  14. [14]

    Winning customer loyalty in an automotive company through Six Sigma: a case study,

    M. Kumar, J. Antony, F. J. Antony and C. N. Madu, "Winning customer loyalty in an automotive company through Six Sigma: a case study," Qual. Reliab. Eng. Int., vol. 23, no. 7, pp. 849-866, 2007

    2007

  15. [15]

    Production, https://www.fticonsulting.com/insights/articles/covid-19-impact-global-pharmaceutical- medical-product-supply-chain

    COVID-19: Impact on Global Pharmaceutical and Medical Product Supply Chain Constraints U.S. Production, https://www.fticonsulting.com/insights/articles/covid-19-impact-global-pharmaceutical- medical-product-supply-chain

  16. [16]

    Economic effects of coronavirus outbreak (COVID-19) on the world economy,

    N. Fernandes, "Economic effects of coronavirus outbreak (COVID-19) on the world economy," Available at SSRN 3557504, 2020

    2020

  17. [17]

    ISM Report on Business, https://www.ismworld.org/

  18. [18]

    Provider Burnout and Fatigue During the COVID-19 Pandemic: Lessons Learned From a High-Volume Intensive Care Unit,

    F. Sasangohar, S. L. Jones, F. N. Masud, F. S. Vahidy and B. A. Kash, "Provider Burnout and Fatigue During the COVID-19 Pandemic: Lessons Learned From a High-Volume Intensive Care Unit," Anesth. Analg., vol. 131, no. 1, pp. 106-111, 2020

    2020

  19. [19]

    pandemic on the labor market, https://www.bls.gov/cps/effects-of-the-coronavirus-covid-19- pandemic.htm

  20. [20]

    Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic,

    A. Shechter, F. Diaz, N. Moise, D. E. Anstey, S. Ye, S. Agarwal, J. L. Birk, D. Brodie, D. E. Cannone and B. Chang, "Psychological distress, coping behaviors, and preferences for support among New York healthcare workers during the COVID-19 pandemic," Gen. Hosp. Psychiatry, vol. 66, pp. 1-8, 2020

    2020

  21. [21]

    Managing mental health challenges faced by healthcare workers during covid-19 pandemic,

    N. Greenberg, M. Docherty, S. Gnanapragasam and S. Wessely, "Managing mental health challenges faced by healthcare workers during covid-19 pandemic," Bmj, vol. 368, 2020

    2020

  22. [22]

    Medical masks vs N95 respirators for preventing COVID‐19 in healthcare workers: A systematic review and meta‐analysis of randomized trials,

    J. J. Bartoszko, M. A. M. Farooqi, W. Alhazzani and M. Loeb, "Medical masks vs N95 respirators for preventing COVID‐19 in healthcare workers: A systematic review and meta‐analysis of randomized trials," Influenza and Other Respiratory Viruses, 2020

    2020

  23. [23]

    COVID-19: Protecting Healthcare Workers is a priority,

    F. Chirico, G. Nucera and N. Magnavita, "COVID-19: Protecting Healthcare Workers is a priority," Infection Control & Hospital Epidemiology, pp. 1-1, 2020

    2020

  24. [24]

    Economic and social consequences of 39 human mobility restrictions under COVID-19,

    G. Bonaccorsi, F. Pierri, M. Cinelli, A. Flori, A. Galeazzi, F. Porcelli, A. L. Schmidt, C. M. Valensise, A. Scala, W. Quattrociocchi and F. Pammolli, "Economic and social consequences of 39 human mobility restrictions under COVID-19," Proc. Natl. Acad. Sci. U. S. A., vol. 117, no. 27, pp. 15530-15535, 2020

    2020

  25. [25]

    Manufacturing: NAICS 31-33, https://www.bls.gov/iag/tgs/iag31-33.htm#about

  26. [26]

    COVID-19: 20 countries' higher education intra-period digital pedagogy responses,

    J. Crawford, K. Butler-Henderson, J. Rudolph, B. Malkawi, M. Glowatz, R. Burton, P. Magni and S. Lam, "COVID-19: 20 countries' higher education intra-period digital pedagogy responses," Journal of Applied Learning & Teaching, vol. 3, no. 1, pp. 1-20, 2020

    2020

  27. [27]

    Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection,

    M. N. Esbin, O. N. Whitney, S. Chong, A. Maurer, X. Darzacq and R. Tjian, "Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection," Rna, vol. 26, no. 7, pp. 771-783, 2020

    2020

  28. [28]

    Antibody testing will enhance the power and accuracy of COVID-19-prevention trials,

    M. Lipsitch, R. Kahn and M. J. Mina, "Antibody testing will enhance the power and accuracy of COVID-19-prevention trials," Nat. Med., pp. 1-2, 2020

    2020

  29. [29]

    Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling,

    B. L. Hedt, F. van Leth, M. Zignol, F. Cobelens, W. van Gemert, N. V. Nhung, S. Lyepshina, S. Egwaga and T. Cohen, "Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling," Epidemiology, vol. 23, no. 2, pp. 293-300, 2012

    2012

  30. [30]

    Heterogeneous Postsurgical Data Analytics for Predictive Modeling of Mortality Risks in Intensive Care Units,

    Y. Chen and H. Yang, "Heterogeneous Postsurgical Data Analytics for Predictive Modeling of Mortality Risks in Intensive Care Units," Engineering in Medicine and Biology Society (EMBC), Proceedings of 2014 Annual International Conference of the IEEE, pp. 1-5, 2014

    2014

  31. [31]

    Nested Gaussian process modeling and imputation of high-dimensional incomplete data under uncertainty,

    F. Imani, C. Cheng, R. Chen and H. Yang, "Nested Gaussian process modeling and imputation of high-dimensional incomplete data under uncertainty," IISE Transactions on Healthcare Systems Engineering, vol. 9, no. 4, pp. 315-326, 2019

    2019

  32. [32]

    Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients,

    J. E. Zimmerman, A. A. Kramer, D. S. McNair and F. M. Malila, "Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients," Crit. Care Med., vol. 34, no. 5, pp. 1297-1310, 2006

    2006

  33. [33]

    Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit,

    E. P. Raith, A. A. Udy, M. Bailey, S. McGloughlin, C. MacIsaac, R. Bellomo and D. V. Pilcher, "Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit," Journal of the American Medical Association, vol. 317, no. 3, pp. 290-300, 2017

    2017

  34. [34]

    SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description,

    P. G. Metnitz, R. P. Moreno, E. Almeida, B. Jordan, P. Bauer, R. A. Campos, G. Iapichino, D. Edbrooke, M. Capuzzo and J. Le Gall, "SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description," Intensive Care Med., vol. 31, no. 10, pp. 1336-1344, 2005

    2005

  35. [35]

    SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission,

    R. P. Moreno, P. G. Metnitz, E. Almeida, B. Jordan, P. Bauer, R. A. Campos, G. Iapichino, D. Edbrooke, M. Capuzzo and J. Le Gall, "SAPS 3—From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission," Intensive Care Med., vol. 31, no. 10, pp. 1345-1355, 2005. 40

    2005

  36. [36]

    The Mini- Mental State Examination in the early diagnosis of Alzheimer's disease,

    D. Galasko, M. R. Klauber, C. R. Hofstetter, D. P. Salmon, B. Lasker and L. J. Thal, "The Mini- Mental State Examination in the early diagnosis of Alzheimer's disease," Arch. Neurol., vol. 47, no. 1, pp. 49-52, 1990

    1990

  37. [37]

    Heterogeneous recurrence representation and quantification of dynamic transitions in continuous nonlinear processes,

    Y. Chen and H. Yang, "Heterogeneous recurrence representation and quantification of dynamic transitions in continuous nonlinear processes," The European Physical Journal B, vol. 89, no. 6, pp. 155, 2016

    2016

  38. [38]

    Heterogeneous recurrence monitoring and control of nonlinear stochastic processes,

    H. Yang and Y. Chen, "Heterogeneous recurrence monitoring and control of nonlinear stochastic processes," Chaos, vol. 24, no. 1, pp. 013138, 2014

    2014

  39. [39]

    Heterogeneous recurrence T^2 charts for monitoring and control of nonlinear dynamic processes,

    Y. Chen and H. Yang, "Heterogeneous recurrence T^2 charts for monitoring and control of nonlinear dynamic processes," in Proceedings of 2015 IEEE International Conference on Automation Science and Engineering (CASE), Gothenburg, Sweden, 2015, pp. 1066-1071

    2015

  40. [40]

    A practical approach for interpreting multivariate T2 control chart signals,

    R. L. Mason, N. D. Tracy and J. C. Young, "A practical approach for interpreting multivariate T2 control chart signals," Journal of Quality Technology, vol. 29, pp. 396–406, 1997

    1997

  41. [41]

    Causation-Based T2 Decomposition for Multivariate Process Monitoring and Diagnosis,

    J. Li, J. Jin and J. Shi, "Causation-Based T2 Decomposition for Multivariate Process Monitoring and Diagnosis," Journal of Quality Technology, vol. 40, no. 1, pp. 46-58, 2008

    2008

  42. [42]

    Spatiotemporal Models for Region of Interest Analyses of Functional Neuroimaging Data,

    F. D. Bowman, "Spatiotemporal Models for Region of Interest Analyses of Functional Neuroimaging Data," Journal of the American Statistical Association, vol. 102, no. 478, pp. 442-453, 2007

    2007

  43. [43]

    Fully bayesian spatio-temporal modeling of FMRI data,

    W. W. Mark, J. Mark, B. J. Michael and M. S. Stephen, "Fully bayesian spatio-temporal modeling of FMRI data," Medical Imaging, IEEE Transaction On, vol. 23, no. 2, pp. 213-231, 2004

    2004

  44. [44]

    Hierarchical spatio-temporal mapping of disease rates,

    L. A. Waller, B. P. Carlin, X. Hong and A. E. Gelfand, "Hierarchical spatio-temporal mapping of disease rates," Journal of the American Statistical Association, vol. 92, no. 438, pp. 607-615, 1997

    1997

  45. [45]

    Modeling Spatial Variation in Disease Risk: A Geostatistical Approach,

    J. Kelsall and J. Wakefield, "Modeling Spatial Variation in Disease Risk: A Geostatistical Approach," Journal of the American Statistical Association, vol. 97, no. 459, pp. 692-701, 2002

    2002

  46. [46]

    A space-time varying coefficient model: The equity of service accessibility,

    N. Serban, "A space-time varying coefficient model: The equity of service accessibility," The Annals of Applied Statistics, pp. 2024-2051, 2011

    2024

  47. [47]

    The 1970 US draft lottery revisited: a spatial analysis,

    J. Mateu, F. Montes and M. Plaza, "The 1970 US draft lottery revisited: a spatial analysis," Journal of the Royal Statistical Society: Series C (Applied Statistics), vol. 53, no. 1, pp. 219-229, 2004

    1970

  48. [48]

    Spatio-temporal fMRI analysis using Markov random fields,

    X. Descombes, F. Kruggel and D. Y. Von Cramon, "Spatio-temporal fMRI analysis using Markov random fields," IEEE Transactions on Medical Imaging, vol. 17, no. 6, pp. 1028-1039, 1998

    1998

  49. [49]

    Multiscale adaptive basis function modeling of spatiotemporal cardiac electrical signals,

    G. Liu and H. Yang, "Multiscale adaptive basis function modeling of spatiotemporal cardiac electrical signals," IEEE Journal of Biomedical and Health Informatics, vol. 17, no. 2, pp. 484-492, 2013

    2013

  50. [50]

    Spatiotemporal differentiation of myocardial infarctions,

    H. Yang, C. Kan, Y. Chen and G. Liu, "Spatiotemporal differentiation of myocardial infarctions," IEEE Transactions on Automation Science and Engineering, vol. 10, no. 4, pp. 938-947, 2013. 41

    2013

  51. [51]

    Spatiotemporal representation of cardiac vectorcardiogram (VCG) signals,

    H. Yang, S. T. Bukkapatnam and R. Komanduri, "Spatiotemporal representation of cardiac vectorcardiogram (VCG) signals," Biomedical Engineering Online, vol. 11, no. 1, pp. 1-15, 2012

    2012

  52. [52]

    Characterizing the Location and Extent of Myocardial Infarctions with Inverse ECG Modeling and Spatiotemporal Regularization,

    B. Yao, R. Zhu and H. Yang, "Characterizing the Location and Extent of Myocardial Infarctions with Inverse ECG Modeling and Spatiotemporal Regularization," IEEE Journal of Biomedical and Health Informatics, vol. 22, no. 5, pp. 1445-1455, 2017

    2017

  53. [53]

    Physics-driven spatiotemporal regularization for high-dimensional predictive modeling,

    B. Yao and H. Yang, "Physics-driven spatiotemporal regularization for high-dimensional predictive modeling," Scientific Reports, vol. 6, no. 39012, 2016

    2016

  54. [54]

    Population flow drives spatio-temporal distribution of COVID-19 in China,

    J. S. Jia, X. Lu, Y. Yuan, G. Xu, J. Jia and N. A. Christakis, "Population flow drives spatio-temporal distribution of COVID-19 in China," Nature, pp. 1-5, 2020

    2020

  55. [55]

    Sparse Modeling and Recursive Prediction of Space–Time Dynamics in Stochastic Sensor Networks,

    Y. Chen and H. Yang, "Sparse Modeling and Recursive Prediction of Space–Time Dynamics in Stochastic Sensor Networks," Automation Science and Engineering, IEEE Transactions On, vol. 13, no. 1, pp. 215-226, 2016

    2016

  56. [56]

    A systematic review of the availability and efficacy of countermeasures to internal threats in healthcare critical infrastructure,

    S. Walker-Roberts, M. Hammoudeh and A. Dehghantanha, "A systematic review of the availability and efficacy of countermeasures to internal threats in healthcare critical infrastructure," IEEE Access, vol. 6, pp. 25167-25177, 2018

    2018

  57. [57]

    The algorithmic foundations of differential privacy

    C. Dwork and A. Roth, "The algorithmic foundations of differential privacy." Foundations and Trends in Theoretical Computer Science, vol. 9, no. 3-4, pp. 211-407, 2014

    2014

  58. [58]

    Matching known patients to health records in Washington State data,

    L. Sweeney, "Matching known patients to health records in Washington State data," Available at SSRN 2289850, 2013

    2013

  59. [59]

    Netflix cancels contest after concerns are raised about privacy,

    S. Lohr, "Netflix cancels contest after concerns are raised about privacy," New York Times, no. March 13, pp. B3, 2010

    2010

  60. [60]

    Gradient mechanism to preserve differential privacy and deter against model inversion attacks in healthcare analytics,

    A. Krall, D. Finke and H. Yang, "Gradient mechanism to preserve differential privacy and deter against model inversion attacks in healthcare analytics," in - 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC), 2020, pp. 5714-5717

    2020

  61. [61]

    Mosaic Privacy-preserving Mechanisms for Healthcare Analytics,

    A. Krall, D. Finke and H. Yang, "Mosaic Privacy-preserving Mechanisms for Healthcare Analytics," IEEE Journal of Biomedical and Health Informatics, pp. 1-8, 2020

    2020

  62. [62]

    Differential data privacy,

    C. Dwork and F. D. McSherry, "Differential data privacy," US Patent US7698250B2, 2010

    2010

  63. [63]

    Toward practicing privacy,

    C. Dwork and R. Pottenger, "Toward practicing privacy," Journal of the American Medical Informatics Association, vol. 20, no. 1, pp. 102-108, 2013

    2013

  64. [64]

    Privacy-preserving logistic regression,

    K. Chaudhuri and C. Monteleoni, "Privacy-preserving logistic regression," in Advances in Neural Information Processing Systems, 2009, pp. 289-296

    2009

  65. [65]

    Functional Mechanism: Regression Analysis under Differential Privacy,

    J. Zhang, Z. Zhang, X. Xiao, Y. Yang and M. Winslett, "Functional Mechanism: Regression Analysis under Differential Privacy," Proceedings of the VLDB Endowment, vol. 5, no. 11, 2012. 42

    2012

  66. [66]

    Regression model fitting under differential privacy and model inversion attack

    Y. Wang, C. Si and X. Wu, "Regression model fitting under differential privacy and model inversion attack." in International Joint Conference on Artificial Intelligence, 2015, pp. 1003-1009

    2015

  67. [67]

    Stochastic gradient descent with differentially private updates,

    S. Song, K. Chaudhuri and A. D. Sarwate, "Stochastic gradient descent with differentially private updates," in 2013 IEEE Global Conference on Signal and Information Processing, 2013, pp. 245- 248

    2013

  68. [68]

    Calculating an institutional personal protective equipment (PPE) burn rate to project future usage patterns during the 2020 COVID-19 pandemic,

    S. Raja, H. H. Patolia and A. W. Baffoe-Bonnie, "Calculating an institutional personal protective equipment (PPE) burn rate to project future usage patterns during the 2020 COVID-19 pandemic," Infection Control & Hospital Epidemiology, pp. 1-2, 2020

    2020

  69. [69]

    COVID-19 Models for Hospital Surge Capacity Planning: A Systematic Review,

    M. G. Klein, C. J. Cheng, E. Lii, K. Mao, H. Mesbahi, T. Zhu, J. A. Muckstadt and N. Hupert, "COVID-19 Models for Hospital Surge Capacity Planning: A Systematic Review," Disaster Medicine and Public Health Preparedness, pp. 1-17, 2020

    2020

  70. [70]

    Service robots for hospitals: A case study of transportation tasks in a hospital,

    A. G. Ozkil, Z. Fan, S. Dawids, H. Aanes, J. K. Kristensen and K. H. Christensen, "Service robots for hospitals: A case study of transportation tasks in a hospital," in 2009 IEEE International Conference on Automation and Logistics, 2009, pp. 289-294

    2009

  71. [71]

    Learning with a friendly interactive robot for service tasks in hospital environments,

    C. Rafflin and A. Fournier, "Learning with a friendly interactive robot for service tasks in hospital environments," Autonomous Robots, vol. 3, no. 4, pp. 399-414, 1996

    1996

  72. [72]

    Using Artificial Intelligence to Detect COVID- 19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy,

    L. Li, L. Qin, Z. Xu, Y. Yin, X. Wang, B. Kong, J. Bai, Y. Lu, Z. Fang, Q. Song, K. Cao, D. Liu, G. Wang, Q. Xu, X. Fang, S. Zhang, J. Xia and J. Xia, "Using Artificial Intelligence to Detect COVID- 19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy," Radiology, vol. 296, no. 2, pp. E65-E71, 2020

    2020

  73. [73]

    L. Kim, S. Garg, A. O’Halloran, M. Whitaker, H. Pham, E. J. Anderson, I. Armistead, N. M. Bennett, L. Billing and K. Como-Sabetti, "Risk factors for intensive care unit admission and in- hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET)," C...

    2019

  74. [74]

    Semi-Supervised Learning Algorithm for Identifying High-Priority Drug–Drug Interactions Through Adverse Event Reports,

    N. Liu, C. Chen and S. Kumara, "Semi-Supervised Learning Algorithm for Identifying High-Priority Drug–Drug Interactions Through Adverse Event Reports," IEEE Journal of Biomedical and Health Informatics, vol. 24, no. 1, pp. 57-68, 2019

    2019

  75. [75]

    Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19,

    C. Funck-Brentano, L. S. Nguyen and J. E. Salem, "Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19," Lancet, vol. 396, no. 10245, pp. e2-e3, 2020

    2020

  76. [76]

    Welcoming new guidelines for AI clinical research,

    E. J. Topol, "Welcoming new guidelines for AI clinical research," Nat. Med., vol. 26, no. 9, pp. 1318-1320, 2020

    2020

  77. [77]

    Deconstructing the drug development process: the new face of innovation,

    K. I. Kaitin, "Deconstructing the drug development process: the new face of innovation," Clinical Pharmacology & Therapeutics, vol. 87, no. 3, pp. 356-361, 2010

    2010

  78. [78]

    Sensor-based virtual reality for clinical decision support in the assessment of mental disorders,

    B. Niederriter, A. Rong, F. Aqlan and H. Yang, "Sensor-based virtual reality for clinical decision support in the assessment of mental disorders," in - 2020 IEEE Conference on Games (CoG), 2020, pp. 666-669. 43

    2020

  79. [79]

    VR medical support system for cancer patients. Cancer edutainment VR theater (CEVRT) and psychooncological VR therapy (POVRT),

    H. Oyama, T. Miyazawa, M. Aono, R. Ohbuchi and S. Suda, "VR medical support system for cancer patients. Cancer edutainment VR theater (CEVRT) and psychooncological VR therapy (POVRT)," Interactive Technology and Healthcare, pp. 433-438, 1995

    1995

  80. [80]

    VR meets physical therapy,

    T. Bowman, "VR meets physical therapy," Commun ACM, vol. 40, no. 8, pp. 59-60, 1997

    1997

Showing first 80 references.

This paper was first reviewed by deepseek-v4-flash on August 2, 2026.